Evidence mapPaperPMID 33027052Full record

ArticleJournal of pediatric endocrinology & metabolism : JPEM2020

Mechanisms and early patterns of dyslipidemia in pediatric type 1 and type 2 diabetes.

Benjamin Udoka Nwosu, Tony R Villalobos-Ortiz, Gabrielle A Jasmin, Sadichchha Parajuli, Emily Zitek-Morrison, Bruce A Barton

Open access · greenAbstract read
In one paragraph

Article in Journal of pediatric endocrinology & metabolism : JPEM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Benjamin Udoka NwosuDepartment of Pediatrics, Division of Endocrinology, University of Massachusetts Medical School, Worcester, MA, USA.
Tony R Villalobos-OrtizDepartment of Pediatrics, Division of Endocrinology, University of Massachusetts Medical School, Worcester, MA, USA.
Gabrielle A JasminDepartment of Pediatrics, Division of Endocrinology, University of Massachusetts Medical School, Worcester, MA, USA.
Sadichchha ParajuliDepartment of Pediatrics, Division of Endocrinology, University of Massachusetts Medical School, Worcester, MA, USA.
Emily Zitek-MorrisonDepartment of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
Bruce A BartonDepartment of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
University of Massachusetts Chan Medical School · US

Funding

NIDDK NIH HHS R21 DK113353
6 · The paper itself

Abstract

Objectives The is no consensus on the early patterns of lipid-based cardiovascular disease (CVD) risk in youth with either type 1 diabetes (T1D) or type 2 diabetes (T2D). The aim was todetermine the differences in CVD risk, using lipid profiles, in children and adolescents with either T1D or T2D at the time of their first lipid assessment, after stratifying the T1D cohort into remitters and non-remitters based on their honeymoon history. Methods A cross-sectional study of 249 subjects consisting of 73 controls, 53 T2D subjects, and 123 T1D subjects stratified into remitters (n=44), and non-remitters (n=79). Partial clinical remission (PCR) was defined as insulin-dose adjusted HbA1c of ≤9. Pubertal status was determined by Tanner staging. Results After adjusting for age, sex, BMI, race, and pubertal status, T2D patients had significantly higher LDL-C compared to the controls (p=0.022), the remitters (p=0.029), but not the non-remitters (103.1 ± 5.9 mg/dL vs. 91.4 ± 4.2 mg/dL, p=0.49). Similarly, T2D patients had significantly higher non-HDL-C compared to the controls (p=0.006), the remitters (p=0.0002), but not the non-remitters (137.6 ± 7.1 mg/dL vs. 111.71 ± 5.0 mg/dL, p=0.053). Total cholesterol was also significantly higher in T2D patients compared to the controls (p=0.0005), the remitters (p=0.006) but not the non-remitters (183.5 ± 6.6 mg/dL vs. 166.2 ± 4.8 mg/dL, p=0.27). Conclusions Lack of the honeymoon phase in children and adolescents with T1D confers early and significantly increased lipid-based cardiovascular risk to these patients that is similar to the elevated cardiovascular risk seen in T2D.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2AdolescentAdultAge of OnsetCase-Control StudiesChildCohort StudiesCross-Sectional StudiesDyslipidemiasFemaleGlycated HemoglobinHumansLipidsMaleRetrospective StudiesGlycated HemoglobinLipidscardiovascular disease riskchildrendyslipidemiahoneymoon phasetype 1 diabetestype 2 diabetes

Identifiers

PMID33027052
PMCPMC9064486
OpenAlexW3092072202

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.